Skórniak Jakub, Rabalski Lukasz, Szynglarewicz Bartlomiej, Dolega-Kozierowski Bartosz, Kasprzak Piotr, Zietek Marcin, Maciejczyk Adam, Pawlak Edyta, Krejmer-Rabalska Martyna, Skuza Katarzyna, Matkowski Rafal
Breast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Biological Threats Identification and Countermeasure Centre, Military Institute of Hygiene and Epidemiology, Pulawy, Poland.
JAMA Netw Open. 2025 Apr 1;8(4):e256215. doi: 10.1001/jamanetworkopen.2025.6215.
Millions of Ukrainians displaced by war have sought refuge in Poland, posing challenges for cancer care. Determining whether these refugees present with more-advanced breast cancer is crucial for guiding resource allocation.
To evaluate the associations between Ukrainian refugee status and clinical presentation of breast cancer compared with Ukrainian permanent residents in Poland and the general Polish population.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted between February 2021 and February 2024 at a single tertiary oncology center (Lower Silesian Oncology, Pulmonology, and Hematology Centre, Wrocław, Poland) and included adult women with a diagnosis of stage 0 to IV breast cancer, regardless of treatment intent. Participants were categorized as Ukrainian permanent residents (UPRs), Ukrainian war refugees (UWRs), or general Polish population (GPP).
War refugee status (UWR) vs permanent residence (UPR) vs general Polish population (GPP) and a diagnosis of breast cancer.
Primary outcomes were clinical stage (0-IV) at diagnosis, tumor grade (G1-G3), and age at presentation. Stage distributions and odds ratios (ORs) were evaluated using weighted logistic regression, adjusting for age and time period (before the war, first war year, and second war year).
Of 3259 patients, 44 were in the UWR group (mean [SD] age, 52.9 [13.5] years), 72 were in the UPR group (mean [SD] age, 49.9 [11.4] years), and 3143 were in the GPP group (mean [SD] age, 59.5 [12.6] years). Stage III to IV disease occurred in 19 patients (43.2%) in the UWR group vs 849 patients (27.0%) in the GPP group. Adjusted analysis showed that refugees had a 2.00-fold increased odds (95% CI, 1.06-3.76; P = .03) of stage III to IV disease and 2.42-fold increased odds (95% CI, 1.29-4.55; P = .006) of grade 3 tumors.
In this retrospective cohort study, war refugee status was associated with a higher prevalence of aggressive tumor grades and more-advanced stage disease at diagnosis. Although aggressive breast cancer subtypes are more common in younger women, the disproportionate burden of advanced disease in this cohort highlights the impact of health care access barriers and delayed presentation. These findings underscore the need for tailored strategies, such as accessible screening and early diagnostic interventions, to improve outcomes among Ukrainian refugees in Poland.
数百万因战争而流离失所的乌克兰人在波兰寻求庇护,这给癌症护理带来了挑战。确定这些难民是否患有更晚期的乳腺癌对于指导资源分配至关重要。
评估乌克兰难民身份与乳腺癌临床表现之间的关联,并与波兰的乌克兰永久居民和波兰普通人群进行比较。
设计、设置和参与者:这项回顾性队列研究于2021年2月至2024年2月在一个单一的三级肿瘤中心(波兰弗罗茨瓦夫下西里西亚肿瘤、肺病和血液学中心)进行,纳入了诊断为0至IV期乳腺癌的成年女性,无论治疗意图如何。参与者被分为乌克兰永久居民(UPR)、乌克兰战争难民(UWR)或波兰普通人群(GPP)。
战争难民身份(UWR)与永久居民身份(UPR)与波兰普通人群(GPP)以及乳腺癌诊断。
主要结局为诊断时的临床分期(0-IV期)、肿瘤分级(G1-G3)和就诊年龄。使用加权逻辑回归评估分期分布和比值比(OR),并对年龄和时间段(战前、战争第一年和战争第二年)进行调整。
在3259名患者中,UWR组有44名(平均[标准差]年龄,52.9[13.5]岁),UPR组有72名(平均[标准差]年龄,49.9[11.4]岁),GPP组有3143名(平均[标准差]年龄,59.5[12.6]岁)。UWR组有19名患者(43.2%)发生III至IV期疾病,而GPP组有849名患者(27.0%)。调整分析显示,难民发生III至IV期疾病的几率增加了2.00倍(95%CI,1.06-3.76;P = 0.03),发生3级肿瘤的几率增加了2.42倍(95%CI,1.29-4.55;P = 0.006)。
在这项回顾性队列研究中,战争难民身份与诊断时侵袭性肿瘤分级的较高患病率和更晚期疾病相关。尽管侵袭性乳腺癌亚型在年轻女性中更为常见,但该队列中晚期疾病的不成比例负担凸显了医疗保健获取障碍和就诊延迟的影响。这些发现强调了需要制定针对性策略,如可及的筛查和早期诊断干预措施,以改善波兰乌克兰难民的治疗结局。